BISMARCK, N.D. (AP) - North Dakota health officials on Tuesday asked COVID-19 vaccine providers in the state to pause use of the Johnson & Johnson shots on recommendations from federal officials over a rare type of blood clot.
The Centers for Disease Control and Prevention and the Food and Drug Administration said the clots have been reported in six people who received the vaccine in the United States. All six cases occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination.
There are currently no reports of any cases occurring in North Dakota. In the meantime, officials are asking people seeking the vaccine to receive Pfizer or Moderna shots.
North Dakota Immunization Program Director Molly Howell said vaccination against COVID-19 “continues to be safer than risking the disease.”
Copyright © 2021 The Washington Times, LLC.